stockrow
Friday 6 November 2026
Export DH’s income statement to Excel — free account
Definitive Healthcare Corp.
DH Healthcare Health Information Services
Definitive Healthcare Corp.’s revenue for fiscal 2025 (year ended December 2025) was $241.5 million, down 4.24% from fiscal 2024.
- Revenue
- −8.99%
- EPS
- +71.4%
- Free cash flow
- −32.6%
- Total debt
- −5.03%
Quarter to September 2026, against a year earlier
1.16
0.03
+2.65%
Follow DH
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 6 | 5 | 5 |
+8 more TTM periods Free account |
| (54.40%) | (56.15%) | (54.36%) | (28.18%) | ||
| (25.28%) | (26.55%) | (25.74%) | (15.23%) | ||
ROIC |
(95.39%) | (92.23%) | (85.82%) | (38.62%) | |
Return on Tangible Assets |
(116.72%) | (133.71%) | (142.95%) | (122.41%) | |
Average Days of Receivables |
47.38 | 48.58 | 59.66 | 78.55 | |
Free Cash Flow per Share |
0.23 | 0.27 | 0.26 | 0.35 | |
Free Cash Flow |
24.19 | 28.56 | 27.06 | 37.06 | |
Capital Expenditures |
(12.97) | (12.86) | (12.22) | (16.72) | |
| Other line items | |||||
Cash ROIC |
4.51% | 5.37% | 5.09% | 5.11% | |
Accounts Receivable Turnover |
7.12 | 6.80 | 5.82 | 4.59 | |
Accounts Payable Turnover |
7.78 | 9.27 | 8.02 | 8.11 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
37.99 | 28.71 | 38.51 | 22.53 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.02) | (0.01) | (0.01) | (0.05) | |
Research and Development Expense of Revenue |
13.14% | 13.22% | 13.42% | 14.40% | |
Selling, General and Administrative Expense of Revenue |
56.13% | 55.36% | 55.40% | 55.18% | |
Share Based Compensation of Revenue |
10.63% | 10.88% | 11.35% | 12.07% | |
Interest Coverage |
(22.22) | (21.88) | (20.97) | (19.87) | |
Operating CF/Net income |
(0.24) | (0.25) | (0.23) | (0.39) | |
Depreciation/Fixed assets |
0.00 | 19.50 | 20.91 | 21.18 | |
Capex/Depreciation |
0.00 | (0.04) | (0.04) | (0.06) | |
Revenue per Share |
2.13 | 2.20 | 2.28 | 2.26 | |
Operating CF per Share |
0.35 | 0.39 | 0.38 | 0.50 | |
Capex per Share |
(0.12) | (0.12) | (0.12) | (0.16) | |
Capex to Sales |
0.06 | 0.06 | 0.05 | 0.07 |
Columns are period end dates · fundamentals updated 5 Nov 2026